Fast Five Quiz: Are You Prepared to Confront Multiple Myeloma?

Emmanuel C Besa, MD; Dhaval Shah, MD


January 14, 2022

One of the largest population-based studies in the United States from 2006 showed that the prevalence of MGUS was 3.2% in the White general population aged ≥ 50 years, while the rate was even higher in Black persons, at 3.7%.

MGUS is defined by the presence of three criteria:

  • Serum monoclonal M protein (M-protein) concentration < 3 g/dL

  • Bone marrow plasma cell concentration < 10%

  • No evidence of end organ damage

Learn more about the etiology of multiple myeloma.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.